Trends, Opportunities, and Challenges for the Latin American Diabetes Therapeutics Market

Trends, Opportunities, and Challenges for the Latin American Diabetes Therapeutics Market

Innovative Drugs to Launch in the Next 3 Years, Impacting the Insulin and Non-insulin Markets

Research Code: ND63-01-00-00-00
SKU: LS00118-GL-MR_16959


Special Price $1,837.50 save 25 %

In stock


$1,837.50 save 25 %


Pay by invoice



This research service focuses on insulin and non-insulin therapeutics for the treatment of type 1 and 2 diabetes in Latin America. The insulin and non-insulin markets will experience major changes within the next three years, due to the discovery of new drugs. Focus is currently placed on the development of molecules that can help with patients’ adherence to treatment by offering one weekly drug dose for managing the chronic disease. This deliverable includes information regarding market background, dynamics, challenges, trends, and access. The base year is 2013. Also, provided are a detailed analysis of products on the market and in development within Latin America, as well as clinical trial details and projected drugs launch timelines.

Related Research
Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological platforms in biomarkers discovery, validation and development in the drug discovery and development market globally. The research study addresses the major issues and challenges, unmet needs and emerging market & technological trends. The report also outlines market drivers and restraints, recent research and developments, Key Innovations and Companies to watch etc.
More Information
No Index Yes
Podcast No
Author Lucila Rocca
WIP Number ND63-01-00-00-00
Is Prebook No